BEND7
BEN domain-containing protein 7
Also known as: BEND7_HUMAN, C10orf30, FLJ40283
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8N7W2
- Gene
- BEND7
- Ensembl
- ENSG00000165626
- Chromosome
- 10
- Canonical length
- 413 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Nucleoli fibrillar center,Vesicles
OverviewNCBI Gene
Predicted to enable DNA binding activity. Located in extracellular exosome. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
413 residues, UniProt reviewed canonical sequence.
>Q8N7W2|BEND7
1 MEFSERKRSR KSQSFKLVSR DYHHEVYKIP EFSNDVNGEA KETQPIFLGD ESMEIKKQIT
61 GMRRLLNDST GRIYQRVGKE GEKLKEEPQD LDLVWPPRLN SSAEAPQSLH PSSRGVWNEL
121 PPQSGQFSGQ YGTRSRTFQS QPHPTTSSNG ELPVVNSSAG SNCCTCNCQS TLQAILQELK
181 TMRKLMQIQA VGTQNRQQPP ISLICSQRTA VSRKRNKKKK VPPKTVEPLT VKQKPSGSEM
241 EKKSVVASEL SALQAAEHTS PEESRVLGFG IVLESPSSDP EVQLAEGFDV FMPKSQLDSI
301 LSNYTRSGSL LFRKLVCAFF DDKTLANSLP NGKRKRGLND NRKGLDQNIV GAIKVFTEKY
361 CTANHVDKLP GPRDWVQILQ DQIKLARRRL KRGSEIADSD ERLDGIALPP TVVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BEND7 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.58
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- thyroid gland: 23 nTPM
- small intestine: 21 nTPM
- kidney: 20 nTPM
- duodenum: 17 nTPM
- parathyroid gland: 16 nTPM
- retina: 15 nTPM
Single-cell type
- late spermatids: 512 nCPM
- early spermatids: 255 nCPM
- epididymal efferent duct absorptive cells: 231 nCPM
- pituitary stem cells: 230 nCPM
- epididymal efferent duct ciliated cells: 171 nCPM
- corticotrophs: 152 nCPM
Immune cell
- neutrophil: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- pons: 10 nTPM
- cerebellum: 10 nTPM
- choroid plexus: 9.9 nTPM
- midbrain: 8.7 nTPM
- thalamus: 7.6 nTPM
- medulla oblongata: 7.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BEN domain
- BEN domain
- BEN domain-containing protein 7
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BEND7 as an antibody target. Whether an autoantibody or antibody against BEND7 could matter depends on whether native BEND7 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BEND7 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BEND7 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...